Agilent Technologies announced the retirement of Boon Hwee Koh, who served as Chairperson of the Board for nine years and was a director for over two decades. Effective September 4, 2026, Dow R. Wilson succeeded Koh as independent chair. The board also appointed Glenn Boehnlein to fill the vacancy created by Koh's departure. Boehnlein, age 64, previously served as Vice President and CFO of Stryker Corporation from 2016 to 2025 and is designated as an audit committee financial expert. He will serve on the Audit and Finance Committee and Compensation Committee. Agilent Technologies operates in the analytical and clinical laboratory technologies industry.

Agilent Technologies reported third-quarter fiscal 2026 results ending July 31, 2026, with revenue of $1.88 billion, an 8.1% increase year-over-year. GAAP net income was $362 million, or $1.28 per share, while non-GAAP net income reached $459 million, or $1.62 per share. The company raised its full-year fiscal 2026 revenue guidance to a range of $7.49 billion to $7.51 billion and increased non-GAAP EPS expectations to $6.18–$6.21. Agilent operates in the analytical and clinical laboratory technologies industry.

Agilent Technologies, Inc. closed the sale of $600 million in aggregate principal amount of 4.900% Senior Notes due 2032 in a private placement. The notes were issued at 99.968% of their principal amount and will mature on January 15, 2032, with semi-annual interest payments. Agilent Technologies, Inc. is a life sciences, diagnostics, and applied chemical markets company providing laboratory technologies and solutions.